Consumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the United States, the company said, capitalising on the rising popularity of GLP-1 medication. Drugs such as Novo Nordisk 's Wegovy and Eli Lilly' s Zepbound and Foundayo help people to lose weight by mimicking a hormone that keeps the stomach feeling full. Potential side-effects from these GLP-1 drugs include nausea, vomiting, constipation and diarrhea. Some people also experience abdominal pain and stomach cramps. Haleon, which makes Advil pain relief pills, TUMS indigestion tablets and Biotène oral-care gels, said it is working with U.S.
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.